Navigation Links
Perrigo Reports Record Fourth Quarter and Fiscal Year Revenue and Earnings
Date:8/15/2013

#8212;(33.0)Tax effect from stock transactions

—17.2———Repurchases of common stock

(0.1)(12.4)———Balance at June 29, 2013

94.1$
538.5$
77.0$
479.6$
,715.9 

 

 

Table IPERRIGO COMPANYRECONCILIATION OF NON-GAAP MEASURES(in millions, except per share amounts)(unaudited)Three Months EndedConsolidatedJune 29, 2013June 30, 2012% ChangeGAAP*Non-GAAP Adjustments*As Adjusted*GAAP*Non-GAAP Adjustments*As Adjusted*GAAPAs AdjustedNet sales

$
967.2$
8212;$
967.2$
831.8$
8212;$
831.816 %16 %Cost of sales

611.023.9

 (a,b) 

587.1537.913.4

 (a) 

524.514 %12 %Gross profit

356.223.9380.1293.913.4307.321 %24 %Operating expensesDistribution

12.5—12.59.6—9.630 %30 %Research and development

30.9—30.927.00.8

 (f) 

26.314 %18 %Selling and administration

120.89.3

 (a,c) 

111.594.65.0

 (a) 

89.628 %24 %Write-off of in-process research and development

9.09.0

 (d) 

——————Restructuring

2.92.9

 (e) 

—1.71.7

 (g) 

—73 %—Total

176.121.2154.9132.97.5125.532 %23 %Operating income

180.145.1225.2160.920.9181.812 %24 %Interest, net

18.6—18.615.9—15.917 %17 %Other expense, net

0.1—0.10.7—0.7(90)%(90)%Income from continuing operations before income taxes

161.445.1206.6144.320.9165.212
'/>"/>

SOURCE Perrigo
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

Related medicine technology :

1. Perrigo Nutritionals Works with the American Academy of Pediatrics (AAP) on Infant Nutrition Educational Initiative
2. Perrigo Company Will Release Fourth Quarter And Fiscal Year 2013 Results On August 15, 2013
3. Perrigo Receives FDA Tentative Approval For Generic Equivalent To Prandin(R)
4. Perrigo Company Acquires Ophthalmic Product Portfolio From Fera Pharmaceuticals, LLC For An Upfront Payment Of $93 Million
5. New Breakthroughs Allow Companies to Expand their Reach - Research Report on Perrigo, Auxilium, Actavis, Mylan, and Salix
6. Perrigo Launches First-Ever Industry Marketing Campaign For Store Brand OTC Medications
7. Perrigo Reports Record Revenue and Adjusted Earnings
8. Perrigo Company To Release Third Quarter Fiscal Year 2013 Results On May 7, 2013
9. Perrigo Company To Present At The Barclays Global Healthcare Conference
10. Perrigo Company To Present At The RBC Global Healthcare Conference
11. Perrigo Confirms First to File Patent Challenge for Generic Version of Testosterone Gel 1.62%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ) ... 2014 financial results for the period ended June 30, 2014, ... will host a conference call and webcast that day at ... slide presentation relating to the call will be available via ... Call Details To access the live conference call via ...
(Date:7/28/2014)... 28, 2014  ProteinSimple announced today that it has ... new assay allows users to detect all proteins separated ... Western users can analyze proteins without the need for ... changed protein analysis as we know it today. First, the ... - no messy gels, no transfer tanks, no blots, ...
(Date:7/28/2014)... HILDEN , Germany and ... -- , Collaboration aims to ... plasma samples to guide the use of IRESSA  for ... test will build on QIAGEN,s FDA-approved  therascreen   EGFR test ... QIAsymphony family of automated instruments  Project enabled ...
Breaking Medicine Technology:PDL BioPharma to Announce Second Quarter 2014 Financial Results on August 11, 2014 2ProteinSimple Says "Never Run a Gel Again!" 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 3QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 4QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 5QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 6
... Foundation Radiology Group (FRG), the region,s premier provider ... it has been named the Hospital Council of Western ... Pittsburgh-based radiology practice that brings the expertise of a ... across Pennsylvania and the tri-state area. By partnering with ...
... Oct. 18 Fenwal, Inc., a global medical ... safety and availability, announced today it has signed ... sell, market and distribute the AccuVein AV300 vein ... North America. (Photo:   http://photos.prnewswire.com/prnh/20101018/CG83159 ...
Cached Medicine Technology:Hospital Council of Western Pennsylvania Announces Foundation Radiology Group as Newest Partner 2Fenwal Named Exclusive Provider of AccuVein's Award-Winning Vein Illumination Device for Blood and Plasma Centers 2Fenwal Named Exclusive Provider of AccuVein's Award-Winning Vein Illumination Device for Blood and Plasma Centers 3
(Date:7/28/2014)... CW4K was among those invited to ... and Partnership for a Healthier America (PHA) ... group's DrinkUP effort, which encourages people across ... , The seven organizations added included Brita®, First 5 ... Bottle, Santa Clara Valley Water District and The California ...
(Date:7/28/2014)... To commemorate World Hepatitis Day which ... Living with a Disability magazine has published a ... include hepatitis, gastrointestinal hemorrhage, inflammatory bowel disease, short bowel ... article highlights that, in the context of receiving a ... other disabling conditions related to the digestive system must ...
(Date:7/28/2014)... 28, 2014 Building a sense of ... important. Where personal outdoor space is not possible, ... enjoy fun and exercise outside is important. That’s ... in quality commercial playground equipment from APCPLAY. , Old ... Midlothian, Virginia. It is an historic tourist location of ...
(Date:7/28/2014)... Shore Points Capital announced today that it ... Inc., through a recapitalization of the Company led by ... investor in Loftware for over nine years, a period ... provider of enterprise level software solutions for supply chain ... for us, and we are proud of everything the ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Cuidado Casero ... and hospice, PCO, PCA, and PHC in Texas, New Mexico, ... a sponsor of the North Texas Chapter of PAM’s 2014 ... the Peruvian American Medical Society. The North Texas chapter was ... and other professionals interested in improving medical care for the ...
Breaking Medicine News(10 mins):Health News:CannedWater4Kids (CW4K) Among Those Invited to the White House to Support First Lady Michelle Obama in Welcoming Seven New Organizations to DrinkUP 2Health News:CannedWater4Kids (CW4K) Among Those Invited to the White House to Support First Lady Michelle Obama in Welcoming Seven New Organizations to DrinkUP 3Health News:Living with a Disability Magazine Marks World Hepatitis Day on July 28 with New Article on Disabling Digestive Disorders 2Health News:Living with a Disability Magazine Marks World Hepatitis Day on July 28 with New Article on Disabling Digestive Disorders 3Health News:Playground Creates Outdoor Fun for Community at Old Buckingham Station at Midlothian Village (VA) with APCPLAY© 2Health News:Shore Points Capital Announces Sale of Portfolio Company Loftware 2Health News:Cuidado Casero Sponsors Peruvian American Medical Society (PAMS) Gala 2
... Peru, Jan. 14 The National Cancer Coalition ... announce a pilot program to assist cancer patients ... medicines Mylotarg(TM) (gemtuzumab ozogamicin for injection) and Neumega(TM) ... Peruvian Health Ministry participated in a hand-over event ...
... to oust reformers, local union officers unopposedOAKLAND, Calif., ... Sal Rosselli and all 17 other statewide officers ... committee chair Debby Schneider. Their victory comes despite ... Stern to oust reformers in the local union ...
... Protections for Texas NursesAUSTIN, Texas, Jan. 14 ... hospitals will gain even more influence in setting appropriate ... The legislation, authored in the Senate by Sen. Jane ... Donna Howard (D-Austin), and supported by the Texas Nurses ...
... By the time they have been diagnosed with Alzheimer,s ... they cannot give informed consent to participate in research ... decision, but there is no clear policy for this ... increasingly common disease is often stalled. , But a ...
... Obesity continues to increase for women in the ... the ages of 35-44, there are approximately 3.3 million ... women who are obese. A new study published in ... there is an increased risk for midlife obesity among ...
... in French . , Montreal, January 14, 2009 ... progression of breast cancer. According to a recent study from ... in the Journal of Biological Chemistry , the protein ... the spread of tumours. Targeting this protein with drug therapy ...
Cached Medicine News:Health News:NCC and Wyeth Donation to Assist Cancer Patients in Latin America 2Health News:United Healthcare Workers Re-Elect All Statewide Officers 2Health News:Legislation Would Give Texas Nurses Even Stronger Voice in Hospital Staffing 2Health News:Legislation Would Give Texas Nurses Even Stronger Voice in Hospital Staffing 3Health News:Most support Alzheimer's research based on family consent 2Health News:Most support Alzheimer's research based on family consent 3Health News:Economic status affects obesity rates in Mexican-American and white women 2
The D.O.R.C. Silicone Oil is an ultra purified silicone oil which leads a maximum interfacial tension and minimizes interactions between tissues, cells and endo-tamponades media. (Sterile, 10 ml.)...
The D.O.R.C. Silicone Oil is an ultra purified silicone oil which leads a maximum interfacial tension and minimizes interactions between tissues, cells and endo-tamponades media. (Sterile, 10 ml.)...
Eftiar® offers the vitreoretinal surgeon a temporary tamponade for efficient re-attachment of the retina, release of subretinal fluid, dissection of fibro-vascular proliferation and controlling r...
... Stent may become a practice-changing technology for ... treatment of lower urinary tract symptoms (LUTS). ... retention , Men unfit for surgery , ... therapy - TUMT, TUNA, Brachytherapy, Cryotherapy , ...
Medicine Products: